What is the level of liabilities of Cosmo Bio Co this year?
Cosmo Bio Co has a debt balance of 2.43 B JPY this year.
In 2024, Cosmo Bio Co's total liabilities amounted to 2.43 B JPY, a 7.34% difference from the 2.26 B JPY total liabilities in the previous year.
Cosmo Bio Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Cosmo Bio Co's financial stability, operational efficiency, and long-term viability.
By comparing Cosmo Bio Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Cosmo Bio Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Shifts in Cosmo Bio Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Cosmo Bio Co has a debt balance of 2.43 B JPY this year.
The liabilities of Cosmo Bio Co have increased by 7.34% increased compared to the previous year.
High liabilities can pose a risk for investors of Cosmo Bio Co, as they can weaken the company's financial position and impair its ability to meet its obligations.
Low liabilities mean that Cosmo Bio Co has a strong financial position and is able to meet its obligations without overburdening its finances.
An increase in liabilities of Cosmo Bio Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
A decrease in the liabilities of Cosmo Bio Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
Some factors that can influence the liabilities of Cosmo Bio Co include investments, acquisitions, operating costs, and sales development.
The liabilities of Cosmo Bio Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
To change its liabilities, Cosmo Bio Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
Over the past 12 months, Cosmo Bio Co paid a dividend of 30 JPY . This corresponds to a dividend yield of about 2.6 %. For the coming 12 months, Cosmo Bio Co is expected to pay a dividend of 30 JPY.
The current dividend yield of Cosmo Bio Co is 2.6 %.
Cosmo Bio Co pays a quarterly dividend. This is distributed in the months of July, January, July, January.
Cosmo Bio Co paid dividends every year for the past 19 years.
For the upcoming 12 months, dividends amounting to 30 JPY are expected. This corresponds to a dividend yield of 2.6 %.
Cosmo Bio Co is assigned to the 'Health' sector.
To receive the latest dividend of Cosmo Bio Co from 3/1/2025 amounting to 36 JPY, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.
The last dividend was paid out on 3/1/2025.
In the year 2023, Cosmo Bio Co distributed 36 JPY as dividends.
The dividends of Cosmo Bio Co are distributed in JPY.
Our stock analysis for Cosmo Bio Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cosmo Bio Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.